Position in ALLO
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$217,599
-$56,779 QoQ
Shares Held
89,180
-55.5% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,293,435,833 across 390 Biotechnology names. ALLO ranks #182 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in ALLO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $217,599 | 89,180 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $274,378 | 200,276 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $179,627 | 144,861 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $144,132 | 127,551 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $156,653 | 107,297 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $222,782 | 104,593 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $226,279 | 80,814 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $158,108 | 67,858 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $246,761 | 55,204 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $173,884 | 54,170 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $535,622 | 168,966 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $823,911 | 165,777 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $652,213 | 132,027 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $33,462 | 5,320 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $77,704 | 7,195 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $79,719 | 6,993 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $120,378 | 13,214 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $580,253 | 38,891 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $525,178 | 20,435 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $281,403 | 10,790 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $187,866 | 5,322 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $882,919 | 34,981 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,098,378 | 29,127 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $874,896 | 20,432 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $557,868 | 28,697 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||